Related Experiment Video
Updated: Aug 7, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
[Large atrial septal defects in adults: results of attempted systematic percutaneous closure]
Insights
Percutaneous closure of large atrial septal defects (ASDs) over 40 mm is feasible using the Amplatzer device. This technique offers a reasonable success rate with no increased risks compared to smaller ASD closures.
Area of Science:
- Cardiology
- Interventional Cardiology
Context:
- Percutaneous closure of ostium secundum atrial septal defects (ASDs) has been standard since 1998.
- Closure was limited by device size, typically up to 40 mm.
Purpose:
- To evaluate the feasibility and success of percutaneous closure for ASDs exceeding 40 mm using the Amplatzer prosthesis.
Summary:
- 17 patients with ASDs >40 mm underwent attempted percutaneous closure.
- Prosthesis insertion was challenging, requiring specialized techniques.
- Successful closure was achieved in 16 out of 17 patients, with no complications or residual shunts.
Impact:
- Very large ASDs (>40 mm) can be successfully closed percutaneously with the Amplatzer device.
- This approach provides a safe alternative for patients with large defects.
- Outcomes are comparable to those seen in smaller ASDs.
Abstract:
Percutaneous closure of ostium secundum atrial septal defects became routine practice from 1998 but remained limited by the size of their diameter at balloon calibration. In March 2004, after an experience of 551 patients, the maximum admissible diameter (40 mm), the biggest size available of the Amplatzer prosthesis, could often be exceeded. The essential anatomical condition was the presence of a circumferential edge--even minimal--except adjacent to the aorta where its absence was not a problem. From 31/03/04 to 31/12/05, 17 patients, 17 to 58 years of age, were included and underwent attempted percutaneous closure by the usual protocol. The insertion of the prosthesis was difficult in every case. It required the use of several techniques to orientate the prosthesis in a satisfactory plane without risking tearing part of the residual atrial septum. The attempt was successful in 16 of the 17 patients. The one failure occurred in a patient with complete absence of a posterior edge. The postoperative course was uncomplicated without residual shunt or displacement of the occluder in the follow-up studies. The authors conclude that very big atrial septal defects with diameters of over 40 mm may be closed percutaneously with the Amplatzer device with a reasonable chance of success. These attempts do not expose the patient to any particular risk and the results, in successful attempts, are comparable to those observed in smaller atrial septal defects.

